The opening gambit: CheckMate 159 and the immunotherapy neoadjuvant era in non-small cell lung cancer
@article{ACTR8571,
author = {Igor Gómez-Randulfe and Raffaele Califano},
title = {The opening gambit: CheckMate 159 and the immunotherapy neoadjuvant era in non-small cell lung cancer},
journal = {AME Clinical Trials Review},
volume = {1},
number = {0},
year = {2023},
keywords = {},
abstract = {},
issn = {3005-6152}, url = {https://actr.amegroups.org/article/view/8571}
}